glp 1 alzheimers Frontiers Weight-Loss Drugs May Reduce Buildup

Findings In New York City, 56.2% of patients prescribed a GLP-1 have a documented type 2 diabetes diagnosis

The American Diabetes Association (ADA) guidelines updated in 2023 recommend GLP-1 receptor agonists as a preferred treatment option for many patients with type 2 diabetes, particularly those with or at high risk for cardiovascular disease or kidney disease

You draw your dose with a syringe, allowing precise microdosing and reducing waste

These drugs are primarily approved for treating type 2 diabetes, so coverage is usually only available if a patient with PCOS also has type 2 diabetes or obesity as a related condition

Supports Healthy Digestion*

Awareness is up since July 2023, when about one in five (19%) said they heard a lot about the drugs. About eight in ten (79%) adults who have taken GLP-1 drugs report getting these drugs or a prescription for them from their primary care doctor or a specialist